You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 16, 2025

Profile for Taiwan Patent: I468190


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Taiwan Patent: I468190

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Mar 14, 2031 Sanofi Aventis Us AUBAGIO teriflunomide
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Taiwan Patent TWI468190

Last updated: July 30, 2025


Introduction

Taiwan Patent TWI468190 pertains to a pharmaceutical-related invention filed with the Intellectual Property Office of Taiwan. This analysis aims to elucidate the scope of the patent, dissect its claims, and evaluate its positioning within the global patent landscape. Such an assessment provides essential insights for stakeholders—including drug developers, competitors, and legal entities—regarding the patent’s enforceability and strategic importance.


Patent Overview

Patent Number: TWI468190
Filing Date: [Date not provided]
Publication Date: [Date not provided]
Applicant/Assignee: [Not specified; refer to original document]
Field: Pharmaceutical, likely involving therapeutic compounds, formulations, or delivery mechanisms.

The patent appears to focus broadly on a novel pharmaceutical compound or formulation intended for therapeutic use, with potential claims covering compound structure, preparation methods, and therapeutic applications.


Scope of Patent TWI468190

Core Focus

Based on typical filings in this domain, TWI468190 likely claims a new chemical entity, a specific formulation, or a therapeutic method involving a known or novel compound.

Key aspects include:

  • Chemical composition:
    Claims may encompass specific molecular structures with defined functional groups, stereochemistry, and substitutions designed to enhance efficacy, stability, or bioavailability.

  • Preparation process:
    Claims could specify process steps for synthesizing the compound, emphasizing purification methods or reaction conditions that confer advantages over prior art.

  • Therapeutic use:
    Claims may extend to methods of treating particular diseases, such as cancers, infectious diseases, or metabolic disorders, using the claimed compound or formulation.

  • Delivery mechanisms:
    Claims could involve innovative delivery systems, controlled-release formulations, or targeted delivery methods to increase therapeutic efficacy.

Claim Types and Hierarchy

Independent Claims:
Typically define the broadest scope, such as a compound or method with minimal limitations to ensure broad patent protection.

Dependent Claims:
Refine the independent claims by adding specific features like chemical substituents, process details, or particular therapeutic indications, narrowing but strengthening the patent's scope in specific embodiments.

Scope Evaluation

  • Broadness:
    If the independent claims are drafted generically, they might cover a wide array of derivatives or uses, providing extensive protection.

  • Specificity:
    Highly specific claims limit the patent’s scope but offer stronger defensibility against design-arounds.

  • Potential Overlaps:
    The scope’s breadth should be evaluated against prior patents and published literature to assess novelty and inventive step.


Claims Analysis

Given the absence of the original claim set, a simulated deduction based on standard pharmaceutical patent structures is provided:

Sample Independent Claim (Hypothetical)

"A compound of formula I, wherein the variables in the chemical structure are defined as follows, exhibiting anti-inflammatory activity."

Substantive Elements

  • Structural Formula:
    The claim likely covers a specific chemical scaffold with defined substituents, possibly including stereochemistry or isomeric forms.

  • Use Claim:
    Methods of treating specific ailments with the compound.

  • Process Claim:
    Steps for synthesizing the compound, emphasizing novel reaction conditions or intermediates.

Claim Dependencies

  • Additional features such as salt forms, solvates, or polymorphs.

  • Variants with enhanced pharmacokinetic properties.

  • Combination claims with other active agents for synergistic effects.

Strengths and Vulnerabilities

  • Strengths:
    Carefully drafted claims encompassing broad chemical classes, therapeutic methods, and delivery forms offer extensive protection.

  • Vulnerabilities:
    Overly broad claims risk invalidation if prior art discloses similar structures. Narrow claims that rely heavily on specific structures or methods could be circumvented by minor modifications.


Patent Landscape and Comparative Analysis

Global Patent Context

  • Overlaps with International Patents:
    The scope likely overlaps with filings under the Patent Cooperation Treaty (PCT) and filings in major markets such as China, US, EU, and Japan. Similar patents globally may target the same chemical class or therapeutic area.

  • Prior Art Search:
    The inventive step would depend on whether similar structures or uses have been disclosed previously. For example, prior patents in chemical and pharmaceutical databases such as WIPO PATENTSCOPE, Espacenet, and USPTO records are relevant.

  • Key Competitors:
    Major pharmaceutical companies working on similar compounds or therapeutic areas would be keen on the scope and claims to evaluate competition and potential litigation risks.

Claims Overlap and Innovativeness

  • The patent’s strength lies in claim novelty—either through unique chemical modifications, improved synthesis, or novel therapeutic claims.

  • Patents that are narrowly drafted tend to face easier workarounds but are easier to defend. Conversely, broader claims offer more comprehensive protection but are more vulnerable to validity challenges.

Legal and Strategic Considerations

  • Patent Validity:
    Requires demonstrating novelty, inventive step, and industrial applicability against existing disclosures.

  • Freedom-to-Operate (FTO):
    Stakeholders must analyze whether commercial development around the patent infringes existing rights or whether the patent effectively blocks competitors.

  • Lifecycle Management:
    Patent families related to TWI468190, including divisional or continuation applications, can extend protection or enable diversification.


Concluding Remarks

Patent TWI468190 appears to cover a significant segment of a novel pharmaceutical compound or formulation, with claims likely encompassing chemical structures, methods of use, and preparation processes. Its scope's robustness depends heavily on the patent drafting strategy and the prior art landscape.

Given the competitive pharmaceutical arena, strategic positioning around such a patent necessitates ongoing landscape monitoring, continuous innovation, and thorough legal validation to maximize commercial advantage and defendability.


Key Takeaways

  • Comprehensive Claim Drafting:
    To ensure broad yet defensible protection, claims should balance generality with specificity, carefully navigating prior art.

  • Global Patent Strategy:
    Align Taiwan patent protection with filings in key jurisdictions to reinforce worldwide market exclusivity.

  • Prior Art Vigilance:
    Regular prior art searches and landscape assessments help preempt invalidation and sharpen patent claims.

  • Therapeutic Focus:
    Claims related to specific diseases or delivery mechanisms can add valuable niche protection.

  • Innovation Continuity:
    Supplementing the patent with follow-up applications enhances lifecycle management and technological robustness.


FAQs

1. What is the typical scope of pharmaceutical patents like TWI468190?
They generally encompass chemical compounds, preparation methods, pharmaceutical formulations, and therapeutic use claims, aiming to secure broad protection over novel drugs and their applications.

2. How can the scope of claims impact patent enforceability?
Broader claims provide extensive coverage but are more susceptible to validity challenges, whereas narrow claims are easier to defend but offer limited protection.

3. What is the significance of patent landscape analysis in pharma?
It identifies existing patents, potential freedom-to-operate issues, and opportunities for differentiation, informing R&D and legal strategies.

4. How does Taiwan patent law influence pharmaceutical patent strategy?
Taiwan's patent system emphasizes novelty, inventive step, and industrial applicability; understanding local requirements helps in effective patent drafting and enforcement.

5. What are the main challenges in patenting pharmaceutical inventions?
Overcoming prior art, demonstrating inventive step, securing broad claims without risking invalidation, and maintaining patent validity during lengthy drug development timelines.


References:

[1] WIPO PATENTSCOPE database.
[2] Espacenet patent search.
[3] Taiwan Intellectual Property Office (TIPO) official resources.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.